NovaScan welcomes Dr Charles Link to lead efforts in targeted drug delivery and to the NovaScan Board of Directors
January 15th, 2020 by NovaScan 

NovaScan, an emerging clinical stage oncology company, is pleased to announce that Charles ‘Chuck’ Link MD, FACS has joined the Board of...

NovaScan Wins First Prize and Third Place in two International Competitions
November 15th, 2019 by NovaScan 

November 15, 2019 NovaScan, an oncology company based in Chicago and Milwaukee, was awarded first prize in the BioPharma category in the I...

NovaScan Presented at American Society of Breast Surgeons Annual Meeting
July 10th, 2018 by NovaScan 

NovaScan recently presented in a poster session at the 2018 Annual Meeting of the American Society of Breast Surgeons, where the company pre...

NovaScan Clincal Results Published in top Dermatology Journal
May 19th, 2018 by NovaScan 

NovaScan’s clinical results in Mohs surgery were published in the highly regarded Journal of the American Academy of Dermatology. The arti...

blog-post-image
NovaScan in the Press
January 2nd, 2018 by NovaScan 

NovaScan was recently featured in the Milwaukee Journal Sentinel, describing our recent progress in commercializing our MarginScan device fo...

Poster Session at the ACMS Annual Meeting
December 3rd, 2017 by NovaScan 

NovaScan participated in a poster session at the 2017 American College of Mohs Surgeons Annual Meeting, where the company presented A Rapid Method for Detecting Non-Melanoma Skin Cancer in Mohs Microg...

NovaScan's Dr. John Shell to Present at NIH Sponsored Conference
November 23rd, 2017 by NovaScan 

NovaScan Senior Scientist John Shell, Ph.D. has been selected to present in a poster session at a Special Topics Conference on Healthcare In...

blog-post-image
PROPEL Announces NovaScan as 2016 Business Plan Competition Winner
April 21st, 2016 by NovaScan 

PROPEL, dedicated to increasing the number and success rate of early-stage life sciences companies in Illinois, announced on April 19 at the...